3D Parametric Model of Human Airways for Particle Drug Delivery and Deposition Optimization

Huimin Liu^*
*Correspondence: Huimin Liu, Department of Biomedical Sciences, Humanitas University, Milan, Italy, Email:

Introduction

The human respiratory system plays a crucial role in delivering oxygen to the bloodstream and removing carbon dioxide. The lungs, consisting of a complex network of airways, facilitate the exchange of gases. However, the airways' anatomical structure also presents challenges when it comes to delivering drugs, particularly in the form of inhaled particles. Particle drug delivery to the lungs has become a common approach for treating a variety of respiratory conditions such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and cystic fibrosis. The efficiency of drug deposition in the lungs is determined by several factors, including the particle size, airflow patterns, and the geometry of the airway passages. To optimize the delivery and deposition of inhaled particles, a detailed understanding of the airways and their interaction with the particles is necessary. A parametric 3D model of human airways can provide valuable insights into these interactions, offering the potential to enhance the efficacy of particle drug delivery systems. The idea behind creating a 3D parametric model of the human airways is to develop a tool that can simulate the airflow and particle dynamics within the respiratory system. Traditional models of the airways often focus on simplified, twodimensional representations or use static structures that do not account for the complex, three-dimensional nature of the airways. In contrast, a parametric 3D model allows for a more accurate representation of the airway geometry, which can be adjusted and customized based on individual patient data. This flexibility makes it possible to account for variations in anatomy, disease conditions, and treatment strategies, thereby improving the predictability and effectiveness of particle deposition.

Description

To construct a 3D parametric model, advanced imaging techniques such as Computed Tomography (CT) scans or Magnetic Resonance Imaging (MRI) are often used to obtain high-resolution images of the airway structures. These images are then processed to create a digital model of the airways, with each airway segment represented as a geometric shape. Parametric design principles are employed to allow modifications to the airway geometry based on various parameters such as the diameter, length, and branching angles of the airways. This approach enables the model to simulate the anatomical features of the airways with high precision, while also providing flexibility to model different airway conditions or interventions. The main advantage of a parametric 3D airway model lies in its ability to simulate and predict the behavior of inhaled particles as they travel through the respiratory system. When a drug is administered via inhalation, the particles must navigate the complex network of airways to reach the target sites in the lungs, such as the alveoli. The size and velocity of the particles, as well as the airflow patterns in the airways, are critical factors that influence deposition efficiency. Particles that are too large may be deposited in the upper airways, while smaller particles may be exhaled or penetrate too deeply into the lungs. The ideal particle size for effective drug delivery is typically in the range of 1 to 5 microns, as these particles are small enough to avoid deposition in the throat and large enough to reach the deep lung regions [1].

In a 3D parametric model, the airflow patterns within the airways are computed based on the geometry of the model. Computational Fluid Dynamics (CFD) simulations are often used to analyze the airflow and predict how particles will behave under different conditions. CFD models take into account the viscosity of the air, the velocity of the airflow, and the complex interactions between the particles and the airway walls. By simulating these conditions, the model can predict how different particle sizes and inhalation profiles will affect drug deposition at various regions of the lungs. One of the key factors influencing particle deposition in the lungs is the airway geometry itself. The airways undergo several branching generations, with each subsequent generation having a smaller diameter and more complex branching patterns. As a result, the airflow and particle dynamics can change significantly from the trachea to the smaller bronchi and bronchioles. In a 3D parametric model, these branching patterns can be represented with high fidelity, allowing for a more accurate prediction of how particles will be distributed across the different airway generations. Additionally, the model can simulate the effects of diseases such as asthma or COPD, which can alter airway geometry and function. For example, in conditions where the airways are constricted or inflamed, the airflow patterns may be altered, potentially affecting drug deposition and efficacy [2].

The ability to modify the airway geometry and simulate different conditions makes the 3D parametric model a powerful tool for optimizing particle drug delivery. By adjusting the parameters of the model, researchers can explore how different factors, such as inhalation flow rate, particle size distribution, and airway geometry, influence the deposition of inhaled particles. For example, a higher inhalation flow rate can increase the velocity of the particles, potentially leading to deeper penetration into the lungs. However, this may also result in reduced deposition efficiency in the smaller airways, where particle capture is more sensitive to flow dynamics. Conversely, lower inhalation flow rates may improve deposition in the smaller airways but may not be as effective in reaching the deep lung regions. By simulating these different scenarios, the model can help identify the optimal conditions for drug delivery to specific regions of the lungs. Another important consideration in particle drug delivery is the interaction between the particles and the airway walls. In addition to the size and velocity of the particles, factors such as particle shape, surface properties, and the presence of mucus can influence how particles interact with the airway surface. Particles with a higher tendency to adhere to the airway walls may be more effectively deposited, but they may also cause side effects if deposited in unwanted areas. The 3D parametric model can incorporate these factors by modeling the surface properties of the airway walls and the behavior of particles as they encounter different types of surfaces [3].

One of the applications of a 3D parametric airway model is the optimization of inhaler devices and drug formulations. Different inhaler devices deliver particles in distinct ways, and the characteristics of the aerosol (such as particle size distribution and velocity) can vary significantly depending on the device used. The model can simulate the deposition of particles from different inhalers to predict which devices and formulations will yield the best therapeutic outcomes. Additionally, the model can be used to test the effectiveness of new drug formulations, enabling the development of more efficient and targeted therapies for respiratory conditions. The 3D parametric model can also aid in personalized medicine by allowing for the customization of treatment plans based on the individual patient's airway structure. Variations in airway geometry and function between patients can lead to differences in drug deposition and treatment efficacy. By generating a personalized model for each patient, the system can predict how a specific inhaled drug will be deposited in the patient's lungs, helping clinicians make more informed decisions about drug choice and delivery method. For example, patients with more pronounced airway narrowing due to asthma may benefit from smaller particles or a specific inhalation technique that maximizes deposition in the smaller airways [4].

Moreover, the model can be extended to simulate other factors that influence particle deposition, such as the effects of respiratory diseases, age, or smoking. For instance, individuals with Chronic Obstructive Pulmonary Disease (COPD) or emphysema may have altered airway diameters and lung compliance, which could affect how particles are deposited. Similarly, elderly patients with reduced lung function may experience changes in airflow patterns that influence drug delivery. By taking these factors into account, the model can help optimize treatment for a wide range of patient populations. In addition to enhancing the understanding of particle dynamics in the airways, the 3D parametric model can contribute to the design of new technologies and therapies. Advances in drug delivery systems, such as smart inhalers or aerosolized biologics, require a thorough understanding of how particles behave in the respiratory system. By providing a platform for simulating and optimizing drug delivery strategies, the 3D model can facilitate the development of new treatments that are both more effective and safer for patients. Despite the significant potential of 3D parametric models in optimizing particle drug delivery, several challenges remain. One of the main obstacles is the complexity of accurately simulating the behavior of particles in the airways, as numerous factors, including turbulence, diffusion, and particle-wall interactions, need to be accounted for. Additionally, obtaining high-quality patient-specific data for model personalization can be time-consuming and expensive. Further advancements in imaging technologies, computational power, and model validation will be necessary to overcome these challenges and fully realize the potential of 3D parametric models in particle drug delivery [5].

Conclusion

In conclusion, a 3D parametric model of human airways for particle drug delivery and deposition optimization represents a powerful tool for advancing the field of respiratory medicine. By simulating the behavior of inhaled particles within the complex airway geometry, these models can provide valuable insights into how drugs are deposited in the lungs and how different factors affect treatment outcomes. This approach has the potential to enhance the efficacy of inhaled therapies, reduce side effects, and improve patient outcomes through personalized treatment plans. With continued research and technological development, 3D parametric models will play an increasingly important role in the optimization of drug delivery systems for respiratory diseases.

References

1. Rahman, Md M., Ming Zhao, Mohammad S. Islam and Kejun Dong, et al. "Nanoparticle transport and deposition in a heterogeneous human lung airway tree: An efficient one path model for CFD simulations." Eur J Pharm Sci 177 (2022): 106279.

Google Scholar, Indexed at

2. Longest, P. Worth, Geng Tian, Navvab Khajeh-Hosseini-Dalasm and Michael Hindle. "Validating whole-airway CFD predictions of DPI aerosol deposition at multiple flow rates." J Aerosol Med Pulm Drug Deliv 29 (2016): 461-481.

Google Scholar, Crossref, Indexed at